title: The glucocorticoid receptor: pivot of depression and of antidepressant treatment?
abstract: Hyperactivity of the hypothalamus-pituitary-adrenal (HPA) axis and increased levels of glucocorticoid hormones in patients with depression have mostly been ascribed to impaired feedback regulation of the HPA axis, possibly caused by altered function of the receptor for glucocorticoid hormones, the glucocorticoid receptor (GR). Antidepressants, in turn, ameliorate many of the neurobiological disturbances in depression, including HPA axis hyperactivity, and thereby alleviate depressive symptoms. There is strong evidence for the notion that antidepressants exert these effects by modulating the GR. Such modulations, however, can be manifold and range from regulation of receptor expression to post-translational modifications, which may result in differences in GR nuclear translocation and GR-dependent gene transcription. The idea that the therapeutic action of antidepressants is mediated, at least in part, by restoring GR function, is consistent with studies showing that decreased GR function contributes to HPA axis hyperactivity and to the development of depressive symptoms. Conversely, excessive glucocorticoid signalling, which requires an active GR, is associated with functional impairments in the depressed brain, especially in the hippocampus, where it results in reduced neurogenesis and impaired neuroplasticity. In this review, we will focus on the GR as a key player in the precipitation, development and resolution of depression. We will discuss potential explanations for the apparent controversy between glucocorticoid resistance and the detrimental effects of excessive glucocorticoid signalling. We will review some of the evidence for modulation of the GR by antidepressants and we will provide further insight into how antidepressants may regulate the GR to overcome depressive symptoms.
authors.affiliation: King's College London, Institute of Psychiatry, Centre for the Cellular Basis of Behaviour (CCBB), Department of Psychological Medicine, Section of Perinatal Psychiatry & Stress, Psychiatry and Immunology (SPI-lab), 125 Coldharbour Lane, London SE5 9NU, UK. Christoph.Anacker@kcl.ac.uk
authors.forename: Christoph
authors.initials: C
authors.lastname: Anacker
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Zunszain
authors.forename: Livia A
authors.initials: LA
authors.lastname: Carvalho
authors.forename: Carmine M
authors.initials: CM
authors.lastname: Pariante
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D008954:Models, Biological; D058990:Molecular Targeted Therapy; D011965:Receptors, Glucocorticoid / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction / Q000235:genetics; D013315:Stress, Psychological / Q000150:complications / Q000235:genetics
chemical_list: D000928:Antidepressive Agents; D011965:Receptors, Glucocorticoid
references.citation: Eur J Neurosci. 2008 May;27(9):2250-61
references.pmid: 18445216
references.citation: Nat Neurosci. 2009 Mar;12(3):342-8
references.pmid: 19234457
references.citation: Psychoneuroendocrinology. 1991;16(6):505-15
references.pmid: 1811246
references.citation: J Neuroendocrinol. 2003 Aug;15(8):811-2
references.pmid: 12834443
references.citation: Ann N Y Acad Sci. 2009 Oct;1179:144-52
references.pmid: 19906237
references.citation: Neuron. 2002 Mar 28;34(1):13-25
references.pmid: 11931738
references.citation: Genes Dev. 2000 Jan 15;14(2):121-41
references.pmid: 10652267
references.citation: Neuron. 2009 May 28;62(4):479-93
references.pmid: 19477151
references.citation: Front Neuroendocrinol. 1993 Apr;14(2):76-122
references.pmid: 8387436
references.citation: J Neurosci. 2000 Dec 15;20(24):9104-10
references.pmid: 11124987
references.citation: J Neurosci. 1992 Sep;12(9):3642-50
references.pmid: 1527603
references.citation: Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12320-2
references.pmid: 11675480
references.citation: Br J Haematol. 2003 Jul;122(2):245-52
references.pmid: 12846893
references.citation: Endocr Rev. 1998 Jun;19(3):269-301
references.pmid: 9626555
references.citation: Brain Res Rev. 2008 Mar;57(2):561-70
references.pmid: 17692926
references.citation: Mol Endocrinol. 2008 Jun;22(6):1331-44
references.pmid: 18337589
references.citation: Mol Psychiatry. 2005 Feb;10(2):160-84
references.pmid: 15356639
references.citation: Psychoneuroendocrinology. 2010 May;35(4):544-56
references.pmid: 19782477
references.citation: Stress. 2008 Nov;11(6):411-24
references.pmid: 19065455
references.citation: Mol Endocrinol. 1992 Sep;6(9):1451-7
references.pmid: 1435789
references.citation: Nat Neurosci. 2002 Nov;5(11):1111-3
references.pmid: 12404003
references.citation: Cancer Res. 1995 Jul 1;55(13):2727-9
references.pmid: 7796394
references.citation: Neuropsychopharmacology. 2008 Dec;33(13):3182-9
references.pmid: 18368033
references.citation: Horm Metab Res Suppl. 1987;16:80-8
references.pmid: 2832300
references.citation: Brain Res. 2006 Oct 30;1117(1):125-34
references.pmid: 16956592
references.citation: Brain Res Mol Brain Res. 1989 Jul;6(1):77-83
references.pmid: 2770454
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):473-8
references.pmid: 15623560
references.citation: Arch Gen Psychiatry. 1992 May;49(5):384-7
references.pmid: 1586274
references.citation: Neuropsychopharmacology. 2000 Nov;23(5):477-501
references.pmid: 11027914
references.citation: Biol Psychiatry. 2006 Dec 15;60(12):1343-9
references.pmid: 16889757
references.citation: J Biol Chem. 1990 Nov 25;265(33):20123-30
references.pmid: 2243084
references.citation: Endocrinology. 2009 May;150(5):2220-8
references.pmid: 19131573
references.citation: Biol Psychiatry. 2006 Apr 1;59(7):619-24
references.pmid: 16325782
references.citation: J Affect Disord. 1991 Aug;22(4):241-8
references.pmid: 1658104
references.citation: Biol Psychiatry. 2001 Mar 1;49(5):391-404
references.pmid: 11274650
references.citation: Endocr Res. 2004 Nov;30(4):859-63
references.pmid: 15666837
references.citation: J Neurosci. 2002 Apr 15;22(8):3251-61
references.pmid: 11943826
references.citation: CNS Spectr. 2002 Feb;7(2):140-2, 144-7
references.pmid: 15220856
references.citation: Mol Cell Biol. 1999 Feb;19(2):1025-37
references.pmid: 9891038
references.citation: Mol Pharmacol. 1997 Oct;52(4):571-81
references.pmid: 9380019
references.citation: Depress Anxiety. 2000;12(1):44-50
references.pmid: 10999245
references.citation: Int J Dev Neurosci. 1998 Jun-Jul;16(3-4):235-9
references.pmid: 9785120
references.citation: Endocrinology. 2001 Jun;142(6):2686-94
references.pmid: 11356720
references.citation: Mol Cell Biol. 1997 Jul;17(7):3947-54
references.pmid: 9199329
references.citation: Pharmacol Rep. 2005 Nov-Dec;57(6):766-73
references.pmid: 16382195
references.citation: J Neurochem. 2000 Oct;75(4):1729-34
references.pmid: 10987856
references.citation: J Neurochem. 2000 Jan;74(1):406-13
references.pmid: 10617146
references.citation: Prog Brain Res. 2007;163:697-722
references.pmid: 17765746
references.citation: J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):150-7
references.pmid: 18304804
references.citation: Neuropsychopharmacology. 2004 Aug;29(8):1538-45
references.pmid: 15127079
references.citation: Ann N Y Acad Sci. 2004 Dec;1032:308-11
references.pmid: 15677438
references.citation: Brain Res. 1993 Jul 2;615(2):304-9
references.pmid: 8364739
references.citation: Neuropsychopharmacology. 2003 Apr;28(4):807-17
references.pmid: 12655328
references.citation: Biol Psychiatry. 2008 Sep 15;64(6):527-32
references.pmid: 18571629
references.citation: Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3908-13
references.pmid: 8632988
references.citation: Endocrinology. 2002 Nov;143(11):4184-95
references.pmid: 12399411
references.citation: Eur J Neurosci. 2007 Dec;26(12):3395-401
references.pmid: 18052970
references.citation: Ann N Y Acad Sci. 1999;896:30-47
references.pmid: 10681886
references.citation: Neuropsychopharmacology. 2009 May;34(6):1395-405
references.pmid: 18704095
references.citation: J Neuroendocrinol. 2006 Aug;18(8):629-31
references.pmid: 16867184
references.citation: J Neuroendocrinol. 1999 Nov;11(11):887-95
references.pmid: 10520140
references.citation: Ann N Y Acad Sci. 2004 Jun;1024:86-101
references.pmid: 15265775
references.citation: Eur J Pharmacol. 2008 Mar 31;583(1):115-27
references.pmid: 18289522
references.citation: Mol Pharmacol. 1992 Jun;41(6):1016-22
references.pmid: 1614406
references.citation: Psychopharmacology (Berl). 2006 Dec;189(2):225-35
references.pmid: 17016711
references.citation: Biochem Biophys Res Commun. 2003 May 16;304(4):720-3
references.pmid: 12727214
references.citation: Behav Pharmacol. 2007 Sep;18(5-6):391-418
references.pmid: 17762509
references.citation: Neuropsychopharmacology. 2009 Oct;34(11):2376-89
references.pmid: 19606083
references.citation: J Biol Chem. 1998 Jun 5;273(23):14315-21
references.pmid: 9603939
references.citation: J Psychiatr Res. 1999 Jul-Aug;33(4):303-8
references.pmid: 10404468
references.citation: Arch Gen Psychiatry. 2000 Mar;57(3):227-8
references.pmid: 10711908
references.citation: Mol Endocrinol. 1998 Jan;12(1):45-56
references.pmid: 9440809
references.citation: Cell. 1990 Sep 21;62(6):1189-204
references.pmid: 2169351
references.citation: Neuropsychopharmacology. 2006 Mar;31(3):628-36
references.pmid: 16160710
references.citation: Mol Endocrinol. 2009 Mar;23(3):281-91
references.pmid: 19095768
references.citation: J Psychiatr Res. 2007 Oct;41(7):553-60
references.pmid: 17023001
references.citation: Br J Pharmacol. 2003 Jul;139(6):1111-8
references.pmid: 12871829
references.citation: Acta Psychiatr Scand. 1997 Jan;95(1):58-61
references.pmid: 9051162
references.citation: Neuropharmacology. 1994 Sep;33(9):1087-93
references.pmid: 7838321
references.citation: Cell Res. 2006 Nov;16(11):857-71
references.pmid: 17088897
references.citation: Arch Gen Psychiatry. 1991 Aug;48(8):693-9
references.pmid: 1652926
references.citation: Steroids. 2005 May-Jun;70(5-7):407-17
references.pmid: 15862824
references.citation: Cell. 2002 Jul 12;110(1):93-105
references.pmid: 12151000
references.citation: Behav Neurosci. 2006 Apr;120(2):249-56
references.pmid: 16719689
references.citation: Nat Neurosci. 2004 Aug;7(8):847-54
references.pmid: 15220929
references.citation: Neuromolecular Med. 2004;5(1):11-25
references.pmid: 15001809
references.citation: Eur J Pharmacol. 1986 Feb 11;121(1):65-71
references.pmid: 2869958
references.citation: Biol Psychiatry. 2000 Oct 15;48(8):755-65
references.pmid: 11063972
references.citation: Endocrinology. 2008 Oct;149(10):5244-53
references.pmid: 18556350
references.citation: Biochem Pharmacol. 2008 Nov 15;76(10):1184-93
references.pmid: 18765234
references.citation: Neuroscience. 1991;44(3):585-90
references.pmid: 1661384
references.citation: Eur Arch Psychiatry Clin Neurosci. 2009 Dec;259(8):499-504
references.pmid: 19644729
references.citation: Biol Psychiatry. 2001 May 1;49(9):753-62
references.pmid: 11331083
references.citation: Mol Endocrinol. 2008 Aug;22(8):1754-66
references.pmid: 18483179
references.citation: J Biol Chem. 1996 Apr 19;271(16):9550-9
references.pmid: 8621628
references.citation: Biol Psychiatry. 2006 Apr 15;59(8):689-95
references.pmid: 16458268
references.citation: J Clin Endocrinol Metab. 2005 Jun;90(6):3505-9
references.pmid: 15755863
references.citation: Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):168-79
references.pmid: 17237843
references.citation: Endocrinology. 2009 Jun;150(6):2709-16
references.pmid: 19213843
references.citation: J Endocrinol. 2009 Jul;202(1):87-97
references.pmid: 19406955
references.citation: Br J Pharmacol. 2000 Jul;130(6):1385-93
references.pmid: 10903980
references.citation: Brain Res. 2004 Nov 12;1026(2):157-67
references.pmid: 15488477
references.citation: Am J Psychiatry. 2004 Nov;161(11):1957-66
references.pmid: 15514393
references.citation: Neuropsychopharmacology. 2007 Dec;32(12):2520-9
references.pmid: 17356567
references.citation: Neuropsychopharmacology. 2002 Dec;27(6):939-48
references.pmid: 12464451
references.citation: J Clin Invest. 1995 Jun;95(6):2435-41
references.pmid: 7769088
references.citation: Brain Res. 2004 Nov 19;1027(1-2):1-10
references.pmid: 15494151
references.citation: Neuropsychopharmacology. 2003 Sep;28(9):1553-61
references.pmid: 12784111
references.citation: Cancer Res. 1993 Sep 1;53(17):3877-9
references.pmid: 8358712
references.citation: Am J Psychiatry. 1984 Nov;141(11):1365-70
references.pmid: 6333828
references.citation: J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):11-21
references.pmid: 17070034
references.citation: Mol Psychiatry. 2006 May;11(5):514-22
references.pmid: 16415915
references.citation: Endocr Rev. 1997 Jun;18(3):306-60
references.pmid: 9183567
references.citation: Neuroendocrinology. 2003 Jul;78(1):12-22
references.pmid: 12869795
references.citation: Neuroscience. 2003;118(4):975-84
references.pmid: 12732243
references.citation: Brain Res. 1985 Dec 16;359(1-2):300-5
references.pmid: 4075151
references.citation: Am J Psychiatry. 2000 Aug;157(8):1334-7
references.pmid: 10910802
references.citation: J Biol Chem. 1999 Jan 8;274(2):1005-10
references.pmid: 9873044
references.citation: J Steroid Biochem Mol Biol. 1992 Oct;43(5):389-94
references.pmid: 1390288
references.citation: J Clin Psychiatry. 1996;57 Suppl 13:49-55; discussion 56-8
references.pmid: 8970504
references.citation: Trends Neurosci. 2008 Sep;31(9):464-8
references.pmid: 18675469